Lewes, DE -- (SBWIRE) -- 08/02/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: AMR Corporation(OTCMKTS:AAMRQ), Soul and Vibe Interactive Inc(OTCBB:SOUL), Nestle SA Reg Shs. Ser. B Spons (ADR)(OTCMKTS:NSRGY), Affymax, Inc.(OTCMKTS:AFFY)
AMR Corporation(OTCMKTS:AAMRQ) ended higher +1.85% and complete the day at $6.04. The total number of shares changed hands during the day was 11.62 million. After opening at $6.11, the stock hit as high as $6.20. However, it traded between $0.36 and $7.15 over the last twelve months.
AMR Corporation (AMR) operates in the airline industry. The Company’s principal subsidiary is American Airlines, Inc. (American). As of December 31, 2011, American provided scheduled jet service to approximately 160 destinations throughout North America, the Caribbean
For How Long AAMRQ will Fight for Profitability? Read This Trend Analysis report
Soul and Vibe Interactive Inc(OTCBB:SOUL) closed yesterday at $1.22, a -5.43% decrease. Around 2.86 million shares were traded. The company is now valued at around $ 133.45 million.
Soul and Vibe Interactive Inc. operates as a video and computer games company that focuses on developing and publishing standout games. It publishes games and games-related content for consoles, mobile devices, and personal computers.
Has SOUL Found The Bottom And Ready To Gain Momentum? Find Out Here
Nestle SA Reg Shs. Ser. B Spons (ADR)(OTCMKTS:NSRGY) moved +0.17 percent higher at $68.09 and traded between $68.00 and $68.24 after opening the day at $68.14. Its performance over the last five days remained 1.25%, which stands at 2.59% for a month. Going back further than one month, 1-year performance after recent close was 4.48%.
Nestle SA is a Switzerland-based holding company of the Nestle Group (the Group) and is principally engaged in the development and production of food and beverage.
For How Long NSRGY Gloss will Attract Investors? Find out via this report
Affymax, Inc.(OTCMKTS:AFFY) shares fell, losing -8.67 percent to close at $1.58. The stock is down around -91.68% this year and -90.5% for the last 12 months. Around 2.59 million shares changed hands yesterday, higher from an-average trading volume of 1.01 million shares.
Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. Peginesatide is a synthetic peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells.
Will AFFY Get Buyers Even After The Recent Rally? Find Out Here
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/